NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, announces a class action on behalf of purchasers of securities of Tenax Therapeutics, Inc. (NASDAQ: TENX) between November 13, 2023 and August 7, 2026, inclusive (the “Class Period”). Tenax is a Phase 3, development stage pharmaceutical company.For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.The Allegations: Rosen Law Firm is Investigating the Allegations that Tenax Th